The expression of Beclin-1 in testicular tissues of non-obstructive azoospermia patients and its predictive value in sperm retrieval rate

Abstract

Background

Beclin-1 is an autophagy gene and higher levels suggest mammalian testicular damage. Our study aims at exploring the role of Beclin-1 in non-obstructive azoospermia (NOA) patients and clarifying the predictive value of Beclin-1for sperm retrieval in microdissection testicular sperm extraction (micro-TESE).

Methods

In the present study, 62 NOA patients were finally recruited. Serum hormone including luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol II (E2), testosterone (T) and prolactin (PRL), as well as testicular volume were measured. Testicular histopathology was diagnosed by two independent pathologists. The expression of Beclin-1 was detected by real-time PCR in testicular tissue.

Results

Our study illustrated that Beclin-1 was differently expressed in three pathological types of NOA. Compared with hypospermatogenesis (HS, P=0.002) or maturation arrest (MA, P=0.049), Beclin-1 showed significantly up-regulated in Sertoli cell-only syndrome (SCOS) group. Moreover, Beclin-1 expression was obviously positive related with serum LH (rho =0.269, P=0.036), meanwhile significantly negative correlation with testicular volume (rho =−0.370, P=0.003), serum T (rho =−0.326, P=0.010), Johnsen score (rho =−0.318, P=0.012), and pathologic type (rho =−0.452, P<0.001). Furthermore, a logistic regression model demonstrated that Beclin-1 is an important predictor of failed sperm retrieval (OR =0.001, P=0.007), which exhibited a pretty AUC =78.6 (P=0.001).

Conclusions

Beclin-1 may play a critical role in spermatogenesis. Elevated Beclin-1 may be obviously associated with lower chances of positive sperm retrieval.

Introduction

Human infertility is a healthcare problem that has a worldwide impact (1). Currently, male factor infertility is increasing and accounts for about half of all infertility cases (2,3). Non-obstructive azoospermia (NOA) is featured by entirely spermatozoa deficiency in semen (4,5). Approximately 1% of males or 10% of infertile males are diagnosed as NOA (6). NOA is a multifactorial disorder and presents with diverse phenotypes (6-8). However, up to now, its molecular pathogenesis remains undefined.

Since the first successful surgical sperm retrieval combination with intracytoplasmic sperm injection (ICSI) made NOA patients to father children in 1994, sperm retrieval after microdissection testicular sperm extraction (micro-TESE) and in vitro fertilization using ICSI is now the first-line treatment for NOA. Remarkably, approximately 50% of infertile patients remain unsuccessful in sperm retrieval (9). A failed micro-TESE brings financial, physical, and emotional burdens for the infertile couple. However, so far, no indicators could accurately predict a positive outcome of sperm retrieval. Therefore, the challenge, however, is not only to improve the spermatogenesis function, but also to discover biomarkers for successful testicular sperm retrieval in NOA patients.

Beclin-1, located at chromosome 17q21 in humans, is the mammalian homolog of the yeast Autophagy-related gene 6 (Atg6) (10). Autophagy has recently been reported to be involved in spermatogenesis and fertilization (11-13). Higher levels of Beclin-1, one of the important autophagy related genes (14), is reported to suggest mammalian testicular damage. For instance, Huang et al. indicated Aflatoxin B1 induced testicular damage and promoted autophagy by increasing the expression of Beclin-1, LC3 and Atg5 in mice testis (15). The results of Wang et al. showed that cadmium accumulates caused testicular injury by increasing autophagy-related protein Beclin1 and LC3 (16). However, so far, the associations between Beclin-1 and infertility remain unknown. Hence, this study was conducted to find some track. We present the following article in accordance with the STARD reporting checklist (available at https://dx.doi.org/10.21037/tau-21-320).

Methods

Subjects

In the present research, both researchers and the data analysts are in blind. A consecutive series of NOA subjects were selected from patients attending the infertility clinic in Assisted Reproduction Center, Northwest women and children’s Hospital (Xi’an, Shaanxi, China) who had a history of infertility of no less than 12 months. Written informed consent forms were obtained from all subjects. Three times semen analyses were conducted after 3–7 days abstinence. Patients with history of chronic diseases, karyotype abnormalities, microdeletions of AZF region on Y chromosome and pelvic/spinal injuries were excluded. This study was conducted in accordance with the Declaration of Helsinki (as revised in 2013) and was approved by the Institutional Ethics Committee of Xi’an Jiaotong University (No. 20180817).

Serum hormone determination

Luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol II (E2), serum testosterone (T) and prolactin (PRL) were detected from Blood samples of each patient according to manufacture instruction by using commercial kits from Roche Biology Company.

Testicular sperm retrieval

The micro-TESE surgery for each patient was conducted by an experienced surgeon. Volume of each testicular was measured in the standard surgery room. Then, a longitudinal incision on the tunica albuginea of the testis was cut to reveal the seminiferous tubules under the professional operating microscope. Tubules with full appearing and opaque, which have possible sperm production, were gently dissected and placed in a petri dish. An experienced embryologist dissected the seminiferous tubules and assessed the presence of sperm with the help of expert microscope. The positive result was confirmed when at least one sperm was found. Thereafter, a large fragment of testicular tissue samples of about 8×4×3 mm³ was cut out, no matter whether the sperm was harvested successfully.

Histopathological examination and Johnsen score

For histological examination, testicular tissue samples were firstly fixed with Bouin’s solution for 24 hours and embedded with paraffin. Then, the slides were stained using Hematoxylin and Eosin solution (HE). Afterwards, all the slides were observed under the microscope by two pathologists. All the pathologic diagnosis were classified into hypospermatogenesis (HS), maturation arrest (MA), and Sertoli-cell-only (SCOS). HS was diagnosed as reduced spermtogeneis with all germ cell types present. MA was defined as premature arrest of spermatogenesis. SCOS was referred to complete deficiency of germ cells. Additionally, the level of spermatogenesis of each testicular sample was measured based on the Johnsen score system (17).

RNA extraction

Total RNA in testicular tissue samples was extracted by RNA Extraction Kit (Takara, Japan). Then RNA was transferred into cDNA Synthesis Kit (Bio-Rad, USA) for next PCR analysis.

Real-time polymerase chain reaction (real-time PCR)

Real-time PCR analysis was performed using SYBR Green SuperMix Kit (Bio-Rad, USA), following the manufacturer’s instructions. The forward primer of Beclin-1 was 5'-AGCTGCCGTTATACTGTTCTG-3', and the reverse was 5'-ACTGCCTCCTGTGTCTTCAATCTT-3'. Meanwhile, the forward primer of housekeeping gene β-actin was 5'-CATGTACGTTGCTATCCAGGC-3', and the reverse was 5'-CTCCTTAATGTCACGCACGAT-3'. The real-time PCR conditions were conducted by Bio-Rad real-time PCR analyzer (Bio-Rad, USA). The reaction processes were detailedly described in our previous study (18). Each sample was detected in triplicate, and the mean Ct (cycle threshold) value was used to analyze the relative expression of Beclin-1 through the comparative 2^-∆∆Ct method.

Statistical analysis

Normality of all the data were tested, and the data with skewed distribution were transformed into normally distributed through the cubed root transformation (18). First, the relative expressions of Beclin-1 among three different pathological types of NOA were evaluated using one-way analysis of variance (ANOVA). Thereafter, the correlations between the relative expression of Beclin-1and the clinical parameters such as age, testicular volume, levels of serum hormone (including LH, FSH, E2, T and PRL), and Johnsen score were estimated through Spearman’s correlation test. Additionally, univariate and multivariable logistic regression analysis were performed to detect influence factors associated with successful sperm retrieval. Considering that pathologic types are ranked data, we score HS as 3, MA as 2, and SCOS as 1 in the present study. Finally, the receiver operating characteristic (ROC) curve analysis was conducted to calculate the area under the curve (AUC) and the optimal cutoff value (Youden’s index) was predicted for the likelihood of successful sperm retrieval.

All statistical analyses were conducted by SPSS statistical software version 18.0 (SPSS Inc., IL, USA).

Results

Clinical characteristics of NOA patients

A total of 62 NOA were involved. According to the results of histological examination, the 62 NOA patients consists of 13 HS (20.97%), 7 MA (11.29%) and 42 SCOS (67.74%).

The clinical characteristics of 62 NOA patients were summarized in Table 1. As shown in Table 1, testicular volume (P<0.001), serum FSH (P<0.001) and serum LH (P=0.028) were significantly aberrantly expressed among three different pathological types of NOA (SCOS, MA, HS). SCOS group demonstrated smaller testicular volumes, higher serum FSH level and higher serum LH level. Age, level of serum T, E2 and PRL showed no statistic differences among HS, MA and SCOS groups.

Table 1. Clinical characteristics of NOA patients.

Clinical characteristics	HS (n=13)	MA (n=7)	SCOS (n=42)	P value
Age (y)	30.69±3.12	32.29±6.2	30.76±5.18	0.741
Testicular volume (mL)	10.92±3.28	8.43±3.64	7.09±3.03	<0.001*
FSH (mIU/mL)	10.52±7.74	18.91±8.27	20.86±6.20	<0.001*
LH (mIU/mL)	6.03±3.49	8.01±2.51	8.78±2.87	0.028*
PRL (ng/mL)	16.16±12.86	12.63±6.69	12.57±6.53	0.409
E2 (pg/mL)	28.79±18.78	24.95±7.99	27.61±11.59	0.842
T (ng/dL)	391.32±177.76	294.85±74.61	356.37±169.31	0.469

*, P<0.05, compared among different groups. NOA, non-obstructive azoospermia; HS, hypospermatogenesis; MA, maturation arrest; SCOS, Sertoli cell-only syndrome; FSH, follicle-stimulating hormone; LH, luteinizing hormone; PRL, prolactin; E2,estradiol II; T, testosterone.

Differential expression of Beclin-1 in three different pathological types of NOA

Figure 1 revealed the Beclin-1 expression profile in three pathological types of NOA patients. As it shown, Beclin-1 mRNA expression level was obviously up-regulated in SCOS group when compared to HS group (P=0.002) and MA group (P=0.049).

Figure 1.

The relative expression of Beclin-1 in three different pathological types of NOA patients. **, P<0.01; *, P<0.05. NOA, non-obstructive azoospermia; HS, hypospermatogenesis; MA, maturation arrest; SCOS, Sertoli cell-only syndrome.

Associations of Beclin-1 with clinical parameters of NOA

The correlations between Beclin-1 and the clinical parameters were shown in Table 2. The relative expression of Beclin-1 in testicular tissue was significantly positively correlated with serum LH (rho =0.269, P=0.036), meanwhile obviously negatively correlated with testicular volume (rho =−0.370, P=0.003), serum T (rho =−0.326, P=0.010), Johnsen score (rho =−0.318, P=0.012) and pathologic type (rho =−0.452, P<0.001) (we score HS as 3, MA as 2, and SCOS as 1).

Table 2. Associations between Beclin-1 expression and clinic-pathological parameters of NOA patients.

Clinicopathological parameters	Beclin-1 expression
	rho	P
Age (y)	−0.102	0.432
Testicular volume (mL)	−0.37	0.003*
FSH (mIU/mL)	0.249	0.053
LH (mIU/mL)	0.269	0.036*
PRL (ng/mL)	−0.114	0.394
E2 (pg/mL)	0.023	0.865
T (ng/dL)	−0.326	0.010*
Pathological type	−0.452	<0.001*
Johnsen Score	−0.318	0.012*

*, P<0.05, significant correlation. NOA, non-obstructive azoospermia; FSH, follicle-stimulating hormone; LH, luteinizing hormone; PRL, prolactin; E2, estradiol II; T, testosterone; rho: spearman correlation coefficient.

The predictive value of Beclin-1 for testicular sperm retrieval

We used univariate and multivariable logistic regression analysis to detect the predictive factors related with testicular sperm retrieval. At first, as shown in Table 3, in univariate logistic analysis, we included all parameters such as age, testicular volume, serum FSH, LH, PRL, E2, T, Johnsen score, and the relative expression of Beclin-1 for analysis. The results showed that the relative expression of Beclin-1 (OR =0.001; 95% CI, 0.001 to 0.111; P=0.007), serum FSH (OR =0.901; 95% CI, 0.830 to 0.979; P=0.014), and serum LH (OR =0.797; 95% CI, 0.646 to 0.984; P=0.035) were the negative predictor for sperm retrieval. To the contrary, Johnsen score (OR =1.877; 95% CI, 1.316 to 2.676; P=0.001) was favorable predictor for sperm retrieval. Moreover, ROC curve analysis exhibited that the relative expression of Beclin-1 (AUC =78.6%, P=0.001; Figure 2A) and FSH (AUC =70.1%, P=0.018; Figure 2A) has statistically significant effect on positive sperm retrieval, respectively. Remarkably, the relative expression of Beclin-1 showed a cutoff value of 0.428, with a sensitivity of 0.556 and specificity of 0.860 for predicted likelihood. Other parameters demonstrated no meaningful predictive value.

Table 3. Univariate and multivariate logistic analyses of the contributing factors for successful sperm retrieval in NOA patients.

Variable	Univariate logistic analysis					Multivariate logistic analysis
	OR	95% CI		P value		OR	95% CI		P value
		Low	High				Low	High
Age (y)	1.025	0.918	1.145	0.663		−	−	−	−
Testicular volume (mL)	1.167	0.987	1.379	0.071		−	−	−	−
FSH (mIU/mL)	0.901	0.830	0.979	0.014*		1.018	0.876	1.183	0.818
LH (mIU/mL)	0.797	0.646	0.984	0.035*		0.892	0.619	1.286	0.541
PRL (ng/mL)	1.018	0.951	1.089	0.609		−	−	−	−
E2 (pg/mL)	0.969	0.918	1.023	0.260		−	−	−	−
T (ng/dL)	1.002	0.998	1.005	0.290		−	−	−	−
Johnsen score	1.877	1.316	2.676	0.001*		1.632	1.043	2.554	0.032*
Beclin-1 expression	0.001	0.001	0.111	0.007*		0.001	0.001	0.707	0.039*

Considering that Johnsen score and pathological diagnostic types existed significant colinearity, we decided to add the Johnsen score (ranked data) but not pathological diagnostic types (categorical data) in our logistic regression models. *, P<0.05. NOA, non-obstructive azoospermia; FSH, follicle-stimulating hormone; LH, luteinizing hormone; PRL, prolactin; E2, estradiol II; T, testosterone; OR, odds ratio; CI, confidence interval.

Figure 2.

ROC curves of the univariate prediction models in NOA patients. (A) Beclin-1 (AUC =78.6%, P=0.001), Age (AUC =54.2%, P=0.623), Johnsen score (AUC =63.1%, P=0.124), Testicular volume (AUC =65.8%, P=0.063), FSH (AUC =70.1%, P=0.018), LH (AUC =66.2%, P=0.057), PRL (AUC =46.1%, P=0.649), E2 (AUC =64.7%, P=0.084), T (AUC =61.3%, P=0.184); (B) the combination between Beclin-1 expression and Johnsen score (AUC =84.8%, P<0.001). ROC, receiver operating characteristic; NOA, non-obstructive azoospermia; FSH, follicle-stimulating hormone; LH, luteinizing hormone; PRL, prolactin; E2,estradiol II; T, testosterone.

Next, multivariate logistic regression was involved in serum FSH, serum LH, Johnsen score and the relative expression of Beclin-1 which were significantly associated with sperm retrieval in univariate logistic analysis Only the relative expression of Beclin-1 (OR =0.001; 95% CI, 0.001 to 0.707; P=0.039) and Johnsen score (OR =1.632; 95% CI, 1.043 to 2.554; P=0.032) were still significantly associated with successful sperm retrieval (Table 3). Further ROC curve analysis indicated that the model with combination of the relative expression of Beclin-1 and Johnsen score showed a better predictive value (AUC =84.8%, P<0.001; Figure 2B). In this prediction formula, A =1.035–6.970× Beclin-1 expression +0.490× Johnsen score.

Discussion

The results firstly demonstrated that Beclin-1 were differently expressed in three pathological types of NOA, and Beclin-1 showed a higher expression in SCOS group when compared with HS and MA group, respectively. Moreover, its expression was obviously positive correlation with serum LH, meanwhile significantly negative correlation with testicular volume, serum T, Johnsen score and pathologic type. Furthermore, a multivariate analysis demonstrated that Beclin-1 showed inverse relationship with testicular sperm retrieval. The cutoff value was 0.428, indicating that males, whose relative expression of Beclin-1 in testis was no more than 0.428, will have positive result in sperm retrieval in standard micro-TESE surgery. Our work has laid the foundations to develop Beclin-1 as a promising biomarker for predicting sperm retrieval and diagnosing NOA.

Spermatogenesis is a highly programmed and intricate physiological process which hinges on dynamic balance of spermatogenetic cells (19-21). Autophagy is a self-eating process inducible by nutrient starvation (22,23). Mounting evidence indicates that autophagy is very important for spermatogenesis (11,24,25). Abnormal autophagy might contribute to spermatogenesis failure. For instance, spermatogenetic injury induced by ethanol depends on the activation of autophagy in Sertoli cells (26). Heat lead to mice spermatogenetic cells death also associated with the stir up of autophagy (21). Formaldehyde exposure might trigger excessive autophagy related with spermatogenesis impairment (27).

The present study found that Beclin-1 were significantly up-regulated expressed in SCOS group when compared with HS and MA group, meaning that Beclin-1 has a higher expression in men with more severe histopathology. Beclin-1 is a vital component of PtdIns3 kinase which stirs up autophagy (28). Beclin-1 complex (includes Beclin-1, VPS34, VPS15 and ATG14) also plays the essential roles in autophagy initiation and regulation (14). These interesting results drove us to focus on Beclin-1 related autophagy is valuable in spermatogenesis. This view was consistent with other authors (11,12). Thus, we have reasons to believe that autophagy-related gene Beclin-1 might be very helpful to guide personalized diagnosis and treatment of NOA. Moreover, Beclin-1 expression was also obviously positive correlation with serum LH, meanwhile significantly negative correlation with testicular volume, serum T, Johnsen score and pathologic type. Remarkably, more severe histopathology was reported to associated with higher level of serum LH (29), smaller testicular volume (30), lower level of serum T (31), and lower Johnsen score (32). Higher-expressed Beclin-1 was also correlated with more severe histopathology. Hence, we are not sure that these associations between Beclin-1 and these clinical features may be due to the severity of histopathology rather than Beclin-1 expression. Further studies are expected to explore the role of Beclin-1 in regulating clinical features.

In addition, the results of univariate logistic analysis indicated that Beclin-1, Johnsen score, serum LH, and serum FSH were potential factors for predicting sperm retrieval. The results about the predictive value of serum FSH and Johnsen score are line with previous studies (30,33,34). For example, Abdel Raheem et al. reported that the Johnsen score ≥8 is the excellent predictor of successful sperm retrieval (33). A meta-analysis of Li et al. summarized that the histopathological type was a meaningful predictor to some extent and most patients with HS may be more likely to get sperm by micro-TESE (30). Guler et al. concluded that FSH is the best predictor of a successful TESE (34).

Moreover, further multivariate logistic analysis additionally disclosures that Beclin-1 and Johnsen score had the most significantly predictive value for predicting sperm retrieval. Beclin-1 was inversely related with successful sperm retrieval, however, Johnsen Score was directly related with successful sperm retrieval. As is known that sperm retrieval rates are primarily associated with pathologic types. Considering that pathologic types are ranked data, we did not add it into our multivariate analysis model. Our result indicated that Beclin-1 and Johnsen score, which had been reported to be related with pathologic types, showed significant predictive value in sperm retrieval. These findings further indicated that Beclin-1 might be vital biomarker for predicting successful sperm retrieval.

Other than the retrospective nature of this study, some non-negligible limitations exist. Firstly, early vs late MA depends on being prior to after meiotic division when the arrest occurs. These are very differing severities of histopathological architecture and should be looked at separately. The present study is limited by the small sample size (7 MA patients). Further study with more MA patients is in needed. Secondly, the subjects of our study are limited in our hospital. Further researches with larger samples from other hospitals or centers are expected to validate our model. Thirdly, the representation of the population is not perfect, which is a common limitation in develop prediction models. Fourthly, the beclin-1 levels in fertile male controls are necessary, and further study are in needed to explore the differential expression of beclin-1 between NOA patients and fertile males, which may lays a foundation for exploring the role and the molecular mechanisms of Beclin-1 in NOA.

Conclusions

In summary, this study firstly demonstrated the expression profile and predictive value of Beclin-1 in NOA, indicating that Beclin-1 might act a vital role in spermatogenesis and it might be a important bio-marker for future prevention and therapy of NOA. However, there is still a long way to go in the exploration of detailed molecular mechanism.

Supplementary

The article’s supplementary files as

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This study was conducted in accordance with the Declaration of Helsinki (as revised in 2013) and was approved by the Institutional Ethics Committee of Xi’an Jiaotong University (No. 20180817). All patients signed informed consent forms.